Email Updates

You are here

Home

13 JANUARY 2023 VOLUME 25 ISSUE 2

Media Coverage

  • Congress’s Bipartisan Deal To Spend Billions More Fighting HIV and Malaria Abroad

    On December 23, while many of us were doing last-minute holiday shopping, Congress passed a big $1.7 trillion spending package, keeping the government funded through September 30, which marks the end of this fiscal year. You’ve likely heard of some of the bill’s more newsworthy provisions, such as a change to the Electoral Count Act to prevent an attempt like Donald Trump’s in 2021 to overturn a presidential election result, or the $45 billion in support for Ukraine’s defense against Russia’s invasion.

    January 13, 2023
    General
    Vox

  • AIDS Denialism Is Still Deadly in 2023

    As we approach the third year of the COVID-19 pandemic, and with shifts in social media moderation, many of us continue to confront science denialism and misinformation daily. While the dangers of misinformation may be new to some, it’s nothing new to HIV/AIDS advocates, who see it as a long-existing barrier to ending the epidemic.

    January 13, 2023
    General
    TheBody

  • 5 Reasons Gonorrhea Is Becoming More Difficult To Treat

    The front page picture of The Star newspaper released into the market on Thursday, January 12, 2023 featured significantly on Kenyans’ WhatsApp and social media statuses. The newspaper’s lead story was titled ‘Super gonorrhea strikes Nairobians’, with the report stating that the Kenya Medical Research Institute (KEMRI) was concerned about the increase in the number of gonorrhea cases that are becoming more difficult to treat among city dwellers.

    January 13, 2023
    STI Vaccines
    The Standard

  • Cannabis Use Linked to Lower ART Adherence in Older Adults With HIV

    Cannabis use was linked to a lower ART adherence among older patients with HIV compared with patients who never use the drug, according to a study published in Open Forum Infectious Diseases. The researchers said their findings are consistent with “most previous” studies showing current cannabis users are more likely to be less than 100 percent adherent to their ART regimen, which must be maintained in order to prevent viral resurgence or mutations causing treatment resistance.

    January 12, 2023
    Treatment
    Healio

  • New Clinical Trials at Leading HIV Center Paused Over Funding Probe

    New clinical trials at a prominent HIV research center in Chicago have been halted for the past nine months, but funding for ongoing studies is in jeopardy and researchers may be laid off as soon as this week as Cook County Health officials continue to investigate a nonprofit that manages the finances of grant-funded research, reports the Chicago Sun Times. The pause also affects new trials for COVID-19, mpox and cancer at the Ruth M. Rothstein CORE Center.

    January 12, 2023
    General
    POZ Magazine

  • Chronic Hepatitis B Patients in Africa Need Improved Diagnostic Tools, Study Results Show

    In the study published in Nature Communications, investigators from the Hepatitis B in Africa Collaborative Network (HEPSANET) tested the use of low-cost, simple blood tests to help decide which individuals with hepatitis B need treatment. “Our findings are timely since [World Health Organization (WHO)] guidelines for hepatitis B are currently undergoing revision.

    January 11, 2023
    General
    Pharmacy Times

  • People With HIV See ‘Dramatic Improvements’ in Mortality, but Some Disparities Persist

    Despite significant strides in decreasing mortality among people with HIV over a two-decade period, sex and racial disparities persist, researchers say. “We know that HIV care and outcomes have dramatically improved over the last 20 years, but disparities still exist at each step of the HIV care continuum that can ultimately lead to differences in mortality rates,” Jessica L. Castilho, MD, MPH, assistant professor of medicine in the division of infectious diseases and assistant professor of health policy at Vanderbilt University Medical Center, told Healio.

    January 11, 2023
    General
    Healio

  • Increased Prevalence of STIs Among Patients Undergoing PrEP Testing

    Higher rates of sexually transmitted infections (STIs) were observed in individuals undergoing diagnostic panels to begin pre-exposure prophylaxis (PrEP) for HIV when compared with the general population, according to the results of a study presented at the International AIDS Conference 2022.

    January 11, 2023
    PrEP
    Consultant 360

  • Trans People Receiving Hormone Therapy in South Africa Are Three Times More Likely To Be Virally Suppressed

    Transgender people were three times more likely to have a suppressed viral load if they were receiving hormone therapy as part of integrated sexual health and gender-affirming services, a large South African study has found. However PrEP outcomes were not better in people who got hormone therapy.

    January 10, 2023
    Treatment
    aidsmap

  • More Evidence COVID Vaccines Work Well for People With HIV

    People living with HIV generally respond well to COVID-19 vaccines—especially if they receive booster shots—thereby dramatically reducing their risk of severe illness and death, according to several recent studies. But those with poorly controlled HIV or advanced immune suppression may not fare as well, underlining the importance of antiretroviral treatment.

    January 10, 2023
    General
    POZ Magazine

  • Meet MGen, a New STI Going Around That No One Is Talking About

    In addition to all the other nasty bugs floating around, like COVID, flu and RSV, health experts are raising the alarm about a sharp rise in sexually transmitted infections (STIs). The World Health Organization estimates more than 1 million STIs are acquired every day worldwide, the majority of which don't cause symptoms. Meanwhile, preliminary data from the Centers for Disease Control and Prevention counted 2.5 million cases of syphilis, chlamydia and gonorrhea in 2021, all on a steep rise compared to previous years.

    January 9, 2023
    General
    Salon

  • After Decades of Efforts, Researchers Hope They’re Closer to a Functional Cure for HIV

    It was 1981 when five patients in California developed symptoms of a mysterious disease. The virus that causes AIDS was identified a few years later, and a blood test for HIV became available in 1985. In the 1980s and early 1990s, contracting HIV was practically a death sentence. Nothing seemed to stop the virus from attacking a patient’s immune system and progressing into AIDS.

    January 9, 2023
    Cure
    Cincinnati Edition

  • Monkeypox and HIV

    Monkeypox—recently renamed mpox—was onE OF the biggest health stories of 2022. Historically a rare disease mostly seen in Central and West Africa, a new outbreak emerged in London in May. Most cases were among men who have sex with men, suggesting sexual transmission. Before long, mpox skyrocketed in cities across Europe and the United States. New cases have since declined dramatically, but major disparities remain, including a high proportion of cases among people living with HIV.

    January 9, 2023
    General
    POZ Magazine

  • I Tried Getting PrEP Online but Decided to Go Through My Doctor

    Ever since my first bareback encounter, I’ve preferred to have condomless, or raw, sex. So heading into the new year, I’ve decided to get back on pre-exposure prophylaxis (PrEP). While browsing on hookup apps―Grindr, Adam4Adam, and Scruff―I’ve noticed a lot of them have online advertisements for PrEP, which, when taken once a day, can protect one from acquiring HIV with an up to 99 percent effectiveness rate.

    January 9, 2023
    PrEP
    TheBody

  • The Link Between HIV and Domestic Violence

    A new study find women who experience intimate partner violence are three times more likely to contract HIV. Regions like sub-Sarahan Africa show the highest prevalence of IPV and HIV worldwide, and sub-Sarahan African women accounted for 63 percent of new HIV infections in 2020.

    January 9, 2023
    General
    Plus Magazine

  • Africa: HIV Remains a Leading Killer in Africa Despite Medical Breakthroughs - How to Eliminate It

    About 38 million people around the world are living with HIV. About 70 percent of them live in Africa. This shows that there is no solution to the AIDS pandemic without a solution in Africa. In 2021, there were 1.5 million new cases of HIV - just over 4,000 cases per day around the world. At the same time, close to 700,000 people died. The big challenge is to address the dual realities of people still dying from HIV in large numbers, and the large numbers of new infections.

    January 8, 2023
    General
    allAfrica

  • Despite Federal Rules, HIV Prevention Drug Still Comes With Costs

    For more than two years, most insurers in Massachusetts and across the country have been required to cover — for free — a medication that reduces the risk of contracting HIV, now a largely preventable virus. But several patients and advocates interviewed by the Globe said insurers have rejected such claims, forcing them to pay out of pocket or stop taking the drug.

    January 8, 2023
    PrEP
    Boston Globe

  • HIV, HBV, HCV Testing up Among Medicaid Enrollees, Although Missed Opportunities Remain

    Testing for HIV, hepatitis B, and hepatitis C increased among US Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

    January 8, 2023
    General
    Healio

  • Curbing the Spread: HIV Self-Test Kit on Doorstep

    From March this year, HIV self-test kit will be available at pharmacies and health facilities across the country for purchase to enable people to self-test to know their HIV status. The Programme Manager of the National STIs and HIV/AIDS Control Programme (NACP), Dr Stephen Ayisi Addo, who disclosed this to the Daily Graphic in Accra last Tuesday, said the introduction of the self-test kit meant that HIV testing could now be done on the doorstep of people and at any space they considered to be private and confidential.

    January 6, 2023
    General
    Business Ghana

  • Remembering the AIDS Crisis and My Lost Friends

    Some people will tell you that the AIDS crisis is over or that there is no reason to care about what happened 40 years ago. But HIV―the virus that causes AIDS when left untreated―is still very present. Now that I am in my 80s, the AIDS crisis is a blur of one precious memory bleeding into another, leaving me with a life of gaping holes where departed friends and colleagues ought to be.

    January 6, 2023
    General
    TheBody

  • HIV Rates Doubled in Ireland Over Past 12 Months, Research Finds

    Recent data released by the Health Protection Surveillance Centre (HPSC) indicates that HIV rates have doubled in Ireland over the past year. Comparing 2022 data to 2021 data, cases of gonorrhea have also increased by 92 percent, chlamydia by 51 percent, syphilis by 26 percent, and genital herpes by 22 percent. Cases are particularly high among young people, and while HIV cases are typically more common among men, one-third of the cases were diagnosed in women.

    January 6, 2023
    General
    GCN

Published Research

Announcements